Table 4.
Antibiotic susceptible profile of methicillin-resistant S. aureus isolated from the hospitalized patients at Hawassa University Comprehensive Specialized Hospital, Sidama regional state, Ethiopia, December 11, 2020 to February 15, 2021.
| Antibiotics tested | All S. aureus, n = 38 |
MRSA, n = 26 |
||||
|---|---|---|---|---|---|---|
| S, n (%) | I, n (%) | R, n (%) | S, n (%) | I, n (%) | R, n (%) | |
| Penicillin | 2 (5.3) | – | 36 (94.7) | – | – | 26 (100) |
| Erythromycin | 11 (28.9) | 25 (65.8) | 2 (5.3) | 3 (11.5) | 21 (80.8) | 2 (7.7) |
| Trimethoprim/ Sulfamethoxazole | 12 (31.6) | – | 26 (68.4) | 6 (23.1) | – | 20 (76.9) |
| Tetracycline | 16 (42.1) | – | 22 (57.9) | 8 (30.8) | – | 18 (69.2) |
| Ciprofloxacin | 26 (68.4) | 2 (5.3) | 10 (26.3) | 14 (53.8) | 2(7.7) | 10 (38.5) |
| Chloramphenicol | 33 (86.8) | – | 5 (13.2) | 21 (80.8) | – | 5 (19.2) |
| Gentamicin | 28 (73.7) | 2 (5.3) | 8 (21) | 16 (61.5) | 2 (7.7) | 8 (30.8) |
| Clindamycin | 36 (94.7) | 2 (5.3) | – | 23 (88.5) | 3 (11.5) | – |